Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Yankner

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Nature|December 21, 1995
Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitroJ Busciglio, B A Yankner
Proceedings of the National Academy of Sciences of the United States of America|December 6, 1994
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo redA Lorenzo, B A Yankner
Methods in Molecular Medicine|February 15, 2011
Normal proteolytic processing of the presenilinsH Hartmann, B A Yankner
Annals of the New York Academy of Sciences|January 17, 1996
Amyloid fibril toxicity in Alzheimer's disease and diabetesA Lorenzo, B A Yankner
Neuroscience Letters|April 29, 1991
An antibody to beta amyloid and the amyloid precursor protein inhibits cell-substratum adhesion in many mammalian cell typesM Chen, B A Yankner
Annual Review of Biochemistry|January 1, 1982
The biology and mechanism of action of nerve growth factorB A Yankner, E M Shooter
The New England Journal of Medicine|December 26, 1991
Seminars in medicine of the Beth Israel Hospital, Boston. beta-Amyloid and the pathogenesis of Alzheimer's diseaseB A Yankner, M M Mesulam
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1979
Nerve growth factor in the nucleus: interaction with receptors on the nuclear membraneB A Yankner, E M Shooter
Nature Medicine|May 1, 2001
Inflammation and Alzheimer disease: the good, the bad, and the uglyS C Weninger, B A Yankner
Journal of Neurochemistry|May 1, 1992
Secretogranin I/chromogranin B is a heparin-binding adhesive proteinM Chen, P Tempst, B A Yankner
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Nature|December 21, 1995
Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitroJ Busciglio, B A Yankner
Proceedings of the National Academy of Sciences of the United States of America|December 6, 1994
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo redA Lorenzo, B A Yankner
Methods in Molecular Medicine|February 15, 2011
Normal proteolytic processing of the presenilinsH Hartmann, B A Yankner
Annals of the New York Academy of Sciences|January 17, 1996
Amyloid fibril toxicity in Alzheimer's disease and diabetesA Lorenzo, B A Yankner
Neuroscience Letters|April 29, 1991
An antibody to beta amyloid and the amyloid precursor protein inhibits cell-substratum adhesion in many mammalian cell typesM Chen, B A Yankner
Annual Review of Biochemistry|January 1, 1982
The biology and mechanism of action of nerve growth factorB A Yankner, E M Shooter
The New England Journal of Medicine|December 26, 1991
Seminars in medicine of the Beth Israel Hospital, Boston. beta-Amyloid and the pathogenesis of Alzheimer's diseaseB A Yankner, M M Mesulam
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1979
Nerve growth factor in the nucleus: interaction with receptors on the nuclear membraneB A Yankner, E M Shooter
Nature Medicine|May 1, 2001
Inflammation and Alzheimer disease: the good, the bad, and the uglyS C Weninger, B A Yankner
Journal of Neurochemistry|May 1, 1992
Secretogranin I/chromogranin B is a heparin-binding adhesive proteinM Chen, P Tempst, B A Yankner
Pageof 5